- |||||||||| Dificid (fidaxomicin) / Merck (MSD), Astellas
Trial primary completion date: C-Diff: Impact of Oral Antibiotic Treatment on C. Difficile (clinicaltrials.gov) - Aug 19, 2016 P4, N=30, Recruiting, Trial primary completion date: Jun 2016 --> Jun 2017 Trial primary completion date: Dec 2016 --> Mar 2017
- |||||||||| Dificid (fidaxomicin) / Merck (MSD), Astellas
Trial primary completion date: Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile? (clinicaltrials.gov) - May 16, 2016 P=N/A, N=100, Recruiting, Initiation date: Dec 2015 --> Dec 2016 | Trial primary completion date: Dec 2017 --> Dec 2018 Trial primary completion date: Mar 2016 --> Jan 2017
- |||||||||| Dificid (fidaxomicin) / Merck (MSD), Astellas
Trial primary completion date: C-Diff: Impact of Oral Antibiotic Treatment on C. Difficile (clinicaltrials.gov) - Jan 21, 2016 P4, N=30, Recruiting, Trial primary completion date: Mar 2016 --> Dec 2016 Trial primary completion date: Dec 2015 --> Dec 2016
|